Peter Parker
Co-Founder & Director @ LabCentral
Cambridge, United States
Peter Parker is a startup investor at LabCentral in Cambridge. Peter joined Ampersand in 1988 and served as a General Partner for 18 years. Subsequently, he joined Cequent Pharmaceuticals, an Ampersand portfolio company, as CEO in 2006 before returning to Ampersand as a Senior Advisor in 2011. Peter currently serves on the boards of ATS Labs and Biomedical Structures. Prior to joining Ampersand, Peterspent 14 years at AMAX. He holds an M.S. in Chemical Engineering from Columbia.
Last updated:
For AI agents: llms.txt
About LabCentral
LabCentral developing novel cancer treatments: Conkwest, Inc, headquartered in DelMar, California, is opening its research laboratory at LabCentral. Conkwest is an innovative life sciences company that is developing and commercializing cell based treatments for cancer and viral infections.
LabCentral Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Gretchen Cook-Anderson
Executive Director, Ignite
|
|||
Johannes Fruehauf
Founder, President & Executive Director
|
|||
Johannes Fruehauf
Founder, President & Executive Director
|
|||
|
Peter Parker
Co-Founder & Director
|
|||
Tim Rowe
Chairman and CEO
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
